| Dr Raj K Rolston, MD | |
|
100 N Academy Ave, Danville, PA 17822-0131 | |
| (570) 271-6338 | |
| Not Available |
| Full Name | Dr Raj K Rolston |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174779680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD069491L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raj K Rolston, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Raj K Rolston, MD 100 N Academy Ave, Danville, PA 17822-0131 Ph: (570) 271-6338 |
News Archive
A review in the December issue of the journal Archives of Pathology & Laboratory Medicine by Paul Bunn Jr, MD, University of Colorado Cancer Center investigator and past president of ASCO, IASLC and AACI describes the current state of lung cancer care.
In his first State of the Union address, President Obama outlined many challenges facing our nation, but fear of root canals should not be one of them. Obama unintentionally reinforced a myth and outdated misconception about the "unpopular" nature of root canal procedures. The AAE, which represents root canal specialists, knows that root canal procedures should not be feared, and hopes the President and all Americans become better informed for the sake of their dental and total body health.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,759,506 entitled "Bipolar Trans Carotenoid Salts and Their Uses." This patent includes drug formulation and use claims relating to Diffusion's entire family of first-in-class new chemical entities. Diffusion Pharmaceuticals is commercializing this family of first-in-class drug candidates to treat serious or life-threatening medical conditions characterized by hypoxia or oxygen deprivation at the cellular level.
Scientists have identified a gene critical to lung maturation in newborns and the production of surfactant, which lines lung tissues and prevents the lungs from collapsing.
› Verified 5 days ago
Dr. Jeffrey W. Prichard, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Myra L. Wilkerson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 Fax: 570-271-6105 | |
Dr. Steven C. Meschter, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. William Quinones, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Conrad Schuerch Iii, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Kai Zhang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 |